Skip to main content
Equibles
NNDM logo

NNDM · Nano Dimension Ltd.

Track NNDM — free

Use NNDM with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about NNDM

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.62 -0.02 (-0.92%)
Market Cap
$343.67M
Shares
210.84M

Nano Dimension Ltd. Earnings Call Transcripts

Every quarterly earnings call for Nano Dimension Ltd. (NNDM) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
· $14.40M −$25.31M '25 Q1 25-06-12 ▲106.4% $29.73M −$69.66M '26 Q1 26-05-07 LATEST ▲12.1% $28.96M −$6.80M '26 Q2 26-08-06
Earnings call
FY26 · Q2
2026-08-06
Nano Dimension Ltd. Q2 FY2026 Earnings Call
Revenue
$28.96M
▲ 12.1% YoY
Diluted EPS
$-0.03
Gross margin
45.9%
Rev · 4q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-15
Nano Dimension and Infinite Epigenetics Investor Conference Call To Discuss Proposed Business Combination
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Nano Dimension Ltd. Q1 FY2026 Earnings Call
Balanced tone Product line divestitures Shareholder skepticism Cash burn and cost reduction
Revenue
$29.73M
▲ 106.4% YoY
Diluted EPS
$-0.34
Gross margin
40.8%
Rev · 3q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-31
Nano Dimension Ltd. Q4 FY2025 Earnings Call
Confident tone AI-powered preventive health and diagnostics platform Proposed business combination with Infinite Epigenetics Capital deployment and shareholder returns
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-19
Nano Dimension Q3 2025 Conference Call
Confident tone AI-powered preventive health and diagnostics platform Shareholder vote and governance process Revenue and commercial scale-up
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-06-12
Nano Dimension Ltd. Q2 FY2025 Earnings Call
Confident tone Proposed business combination with Infinite Epigenetics AI-powered epigenetics platform and proprietary data Market opportunity and chronic disease mission
Revenue
$14.40M
Diluted EPS
$-0.12
Gross margin
40.6%
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-04-30
Nano Dimension Ltd. Q1 FY2025 Earnings Call
Confident tone AI-powered preventive health and diagnostics platform Proposed business combination with Infinite Epigenetics Existing operating businesses under Infinite
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-20
Nano Dimension Ltd. Q3 FY2024 Earnings Call
Confident tone Acquisitions of Desktop Metal and Markforged Revenue and gross margin growth Shareholder activism defense (Murchinson)
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-20
Nano Dimension Ltd. Q2 FY2024 Earnings Call
Confident tone Desktop Metal acquisition Industry 4.0 vision and positioning Quarterly financial results and cash burn reduction
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Nano Dimension Ltd. Q1 FY2024 Earnings Call
Confident tone Reshaping Nano Initiative / Path to Profitability Stratasys Strategic Stake / M&A Discussions Additive Manufacturing Electronics (AME) Applications
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Nano Dimension Ltd. Q4 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-28
Nano Dimension Ltd. Q3 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-29
Nano Dimension Ltd. Q2 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-30
Nano Dimension Ltd. Q1 FY2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Nano Dimension Ltd. Q4 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-09-30
Nano Dimension Ltd. Q3 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-06-30
Nano Dimension Ltd. Q2 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-03-31
Nano Dimension Ltd. Q1 FY2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-12-31
Nano Dimension Ltd. Q4 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-24
Nano Dimension Ltd. Q3 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-18
Nano Dimension Ltd. Q2 FY2021 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
Nano Dimension Ltd. Q4 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-09-30
Nano Dimension Ltd. Q3 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-06-30
Nano Dimension Ltd. Q2 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-03-31
Nano Dimension Ltd. Q1 FY2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Showing 1–25 of 25 earnings calls
Key facts CIK 1643303 CUSIP 63008G203 13F (30d) 100 filings 97 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)